Cancer Research UK logo.
SearchDonate
  • Search

A trial of a drug called methylphenidate for people with tiredness caused by cancer (MePFAC)

Overview

Cancer types:

All cancer types, Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people who have moderate or severe tiredness (fatigue) caused by advanced cancer.

Advanced cancer means that the cancer has spread from where it started to another part of the body. It is for people with any type of cancer that cannot be cured.

Recruitment start: 29 June 2018

Recruitment end: 28 April 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor P Stone

Supported by

Priment Clinical Trial Unit

National Institute for Health Research (NIHR)

NIHR Health Technology Assessment (HTA) programme

University College London (UCL)

Marie Curie Cancer Care

Last reviewed: 12 Jan 2026

CRUK internal database number: 15240

Help and support